Back to Search Start Over

Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline

Authors :
Arrossi, S
Temin, S
Garland, S
Eckert, LO
Bhatla, N
Castellsague, X
Alkaff, SE
Felder, T
Hammouda, D
Konno, R
Lopes, G
Mugisha, E
Murillo, R
Scarinci, IC
Stanley, M
Tsu, V
Wheeler, CM
Adewole, IF
de Sanjose, S
Arrossi, S
Temin, S
Garland, S
Eckert, LO
Bhatla, N
Castellsague, X
Alkaff, SE
Felder, T
Hammouda, D
Konno, R
Lopes, G
Mugisha, E
Murillo, R
Scarinci, IC
Stanley, M
Tsu, V
Wheeler, CM
Adewole, IF
de Sanjose, S
Publication Year :
2017

Abstract

PURPOSE: To provide resource-stratified (four tiers), evidence-based recommendations on the primary prevention of cervical cancer globally. METHODS: The American Society of Clinical Oncology convened a multidisciplinary, multinational panel of oncology, obstetrics/gynecology, public health, cancer control, epidemiology/biostatistics, health economics, behavioral/implementation science, and patient advocacy experts. The Expert Panel reviewed existing guidelines and conducted a modified ADAPTE process and a formal consensus-based process with additional experts (consensus ratings group) for one round of formal ratings. RESULTS: Existing sets of guidelines from five guideline developers were identified and reviewed; adapted recommendations formed the evidence base. Five systematic reviews, along with cost-effectiveness analyses, provided evidence to inform the formal consensus process, which resulted in agreement of ≥ 75%. RECOMMENDATIONS: In all resource settings, two doses of human papillomavirus vaccine are recommended for girls age 9 to 14 years, with an interval of at least 6 months and possibly up to 12 to 15 months. Individuals with HIV positivity should receive three doses. Maximal and enhanced settings: if girls are age ≥ 15 years and received their first dose before age 15 years, they may complete the series; if no doses were received before age 15 years, three doses should be administered; in both scenarios, vaccination may be through age 26 years. Limited and basic settings: if sufficient resources remain after vaccinating girls age 9 to 14 years, girls who received one dose may receive additional doses between age 15 and 26 years. Maximal, enhanced, and limited settings: if ≥ 50% coverage in the priority female target population, sufficient resources, and cost effectiveness, boys may be vaccinated to prevent other noncervical human papillomavirus-related cancers and diseases. Basic settings: vaccinating boys is not recommended. UNLABELLED: It is the view o

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1315699773
Document Type :
Electronic Resource